HEADER SIGNALING PROTEIN,TRANSFERASE/INHIBITOR 24-SEP-20 7K7Z TITLE STRUCTURE OF A HIT FOR G PROTEIN COUPLED RECEPTOR KINASE 2 (GRK2) TITLE 2 INHIBITOR FOR THE POTENTIAL TREATMENT OF HEART FAILURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-ADRENERGIC RECEPTOR KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BETA-ARK-1,G-PROTEIN COUPLED RECEPTOR KINASE 2; COMPND 5 EC: 2.7.11.15; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)/G(T) SUBUNIT COMPND 9 BETA-1; COMPND 10 CHAIN: B; COMPND 11 SYNONYM: TRANSDUCIN BETA CHAIN 1; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: GUANINE NUCLEOTIDE-BINDING PROTEIN G(I)/G(S)/G(O) SUBUNIT COMPND 15 GAMMA-2; COMPND 16 CHAIN: G; COMPND 17 SYNONYM: G GAMMA-I; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GRK2, ADRBK1, BARK, BARK1; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: GNB1; SOURCE 13 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 15 MOL_ID: 3; SOURCE 16 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 17 ORGANISM_COMMON: HUMAN; SOURCE 18 ORGANISM_TAXID: 9606; SOURCE 19 GENE: GNG2; SOURCE 20 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS SERINE/THREONINE PROTEIN KINASE, SIGNALING PROTEIN, TRANSFERASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.C.SPURLINO,C.MILLIGAN REVDAT 4 03-APR-24 7K7Z 1 REMARK REVDAT 3 06-MAR-24 7K7Z 1 REMARK REVDAT 2 04-NOV-20 7K7Z 1 JRNL REVDAT 1 28-OCT-20 7K7Z 0 JRNL AUTH G.XU,M.D.GAUL,Z.LIU,R.L.DESJARLAIS,J.QI,W.WANG,D.KROSKY, JRNL AUTH 2 I.PETROUNIA,C.M.MILLIGAN,A.HERMANS,H.R.LU,D.Z.HUANG,J.Z.XU, JRNL AUTH 3 J.C.SPURLINO JRNL TITL HIT-TO-LEAD OPTIMIZATION AND DISCOVERY OF A POTENT, AND JRNL TITL 2 ORALLY BIOAVAILABLE G PROTEIN COUPLED RECEPTOR KINASE 2 JRNL TITL 3 (GRK2) INHIBITOR. JRNL REF BIOORG.MED.CHEM.LETT. V. 30 27602 2020 JRNL REFN ESSN 1464-3405 JRNL PMID 33038544 JRNL DOI 10.1016/J.BMCL.2020.127602 REMARK 2 REMARK 2 RESOLUTION. 2.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.12_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.15 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.338 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 43058 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.617 REMARK 3 FREE R VALUE TEST SET COUNT : 1988 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.1440 - 6.2717 0.99 3044 148 0.1574 0.1895 REMARK 3 2 6.2717 - 4.9818 0.99 3001 146 0.1931 0.2537 REMARK 3 3 4.9818 - 4.3532 0.99 2973 144 0.1577 0.1903 REMARK 3 4 4.3532 - 3.9557 0.99 2971 144 0.1726 0.2603 REMARK 3 5 3.9557 - 3.6724 0.99 2930 143 0.1918 0.2508 REMARK 3 6 3.6724 - 3.4561 0.99 2958 142 0.2151 0.2856 REMARK 3 7 3.4561 - 3.2831 0.99 2936 144 0.2317 0.3115 REMARK 3 8 3.2831 - 3.1402 0.99 2925 141 0.2445 0.2968 REMARK 3 9 3.1402 - 3.0194 0.99 2944 143 0.2654 0.3344 REMARK 3 10 3.0194 - 2.9153 0.99 2937 142 0.2767 0.3788 REMARK 3 11 2.9153 - 2.8241 0.99 2885 140 0.2738 0.3684 REMARK 3 12 2.8241 - 2.7434 0.98 2936 140 0.2992 0.3379 REMARK 3 13 2.7434 - 2.6712 0.99 2898 140 0.2995 0.3401 REMARK 3 14 2.6712 - 2.6061 0.93 2732 131 0.3088 0.3796 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.387 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.740 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.34 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.48 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 8378 REMARK 3 ANGLE : 0.528 11297 REMARK 3 CHIRALITY : 0.040 1213 REMARK 3 PLANARITY : 0.003 1478 REMARK 3 DIHEDRAL : 13.369 5072 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -9.8779 13.7000 29.0346 REMARK 3 T TENSOR REMARK 3 T11: 0.3935 T22: 0.3191 REMARK 3 T33: 0.3562 T12: 0.0026 REMARK 3 T13: -0.0277 T23: -0.0295 REMARK 3 L TENSOR REMARK 3 L11: 0.5833 L22: 0.4747 REMARK 3 L33: 2.0654 L12: -0.2010 REMARK 3 L13: 0.7063 L23: -0.5358 REMARK 3 S TENSOR REMARK 3 S11: 0.1966 S12: -0.0490 S13: -0.1393 REMARK 3 S21: 0.0215 S22: -0.0160 S23: 0.0164 REMARK 3 S31: 0.3859 S32: 0.1079 S33: -0.1561 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7K7Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-SEP-20. REMARK 100 THE DEPOSITION ID IS D_1000252026. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 80 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43160 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.9600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: GRK2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2% PEG 3350, 0.1M MES PH 6.5, 0.2M REMARK 280 NACL, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 97.33950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.34450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 97.33950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.34450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 46290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -50.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 480 REMARK 465 ASP A 481 REMARK 465 ALA A 482 REMARK 465 PHE A 483 REMARK 465 ASP A 484 REMARK 465 ILE A 485 REMARK 465 GLY A 486 REMARK 465 SER A 487 REMARK 465 PHE A 488 REMARK 465 ASP A 489 REMARK 465 GLU A 490 REMARK 465 GLU A 491 REMARK 465 ASP A 492 REMARK 465 THR A 493 REMARK 465 ALA A 669 REMARK 465 THR G 6 REMARK 465 ALA G 7 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 572 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU A 573 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLU A 107 OG SER A 111 1.97 REMARK 500 OG1 THR B 128 O ASN B 132 2.03 REMARK 500 O THR A 408 NH1 ARG A 431 2.10 REMARK 500 OH TYR A 315 O SER A 334 2.11 REMARK 500 NH2 ARG A 80 OE2 GLU A 116 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 31 102.20 -167.67 REMARK 500 VAL A 53 63.17 -100.33 REMARK 500 CYS A 120 -131.72 -71.39 REMARK 500 HIS A 122 75.29 -118.95 REMARK 500 VAL A 132 -72.69 -57.77 REMARK 500 HIS A 194 -141.33 -106.33 REMARK 500 SER A 247 22.33 -78.19 REMARK 500 HIS A 262 130.03 -171.49 REMARK 500 ASP A 265 -10.54 -152.16 REMARK 500 ARG A 316 6.02 82.28 REMARK 500 ASP A 335 84.74 58.45 REMARK 500 ALA A 339 174.61 -59.21 REMARK 500 LYS A 346 87.59 60.82 REMARK 500 HIS A 348 -128.56 39.71 REMARK 500 ALA A 349 -152.55 -133.28 REMARK 500 LYS A 364 10.20 -69.79 REMARK 500 ASP A 369 -135.09 -115.23 REMARK 500 HIS A 394 22.96 -76.86 REMARK 500 THR A 408 -93.14 -117.97 REMARK 500 ARG A 435 44.87 -149.95 REMARK 500 ARG A 474 33.40 -82.22 REMARK 500 ASN A 478 -151.93 56.94 REMARK 500 LYS A 497 143.28 172.96 REMARK 500 LEU A 498 -159.24 -80.93 REMARK 500 LEU A 499 -74.44 -125.15 REMARK 500 ASP A 500 -102.17 -13.48 REMARK 500 SER A 501 -15.38 -47.59 REMARK 500 THR A 524 -76.46 -135.15 REMARK 500 HIS A 549 12.26 84.83 REMARK 500 LYS A 557 -144.69 -136.78 REMARK 500 PRO A 571 -126.94 -117.66 REMARK 500 LEU A 573 -5.18 146.79 REMARK 500 GLU A 595 127.46 -172.65 REMARK 500 LEU A 601 113.31 -164.70 REMARK 500 ALA B 60 144.97 -176.56 REMARK 500 THR B 87 2.59 85.79 REMARK 500 TRP B 99 40.99 -91.23 REMARK 500 LYS B 127 63.19 -119.47 REMARK 500 ARG B 137 140.11 -177.15 REMARK 500 ASP B 153 -150.03 -149.81 REMARK 500 THR B 164 -15.87 93.43 REMARK 500 THR B 196 7.36 58.33 REMARK 500 HIS B 266 135.48 -177.04 REMARK 500 PHE B 292 1.52 84.73 REMARK 500 ARG B 314 131.62 -39.21 REMARK 500 SER B 334 -15.94 98.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LYS A 346 PRO A 347 -149.93 REMARK 500 PRO A 347 HIS A 348 144.42 REMARK 500 LEU A 498 LEU A 499 -147.69 REMARK 500 LEU A 499 ASP A 500 -148.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue W4G A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 7K7L RELATED DB: PDB DBREF 7K7Z A 30 668 UNP P25098 ARBK1_HUMAN 30 668 DBREF 7K7Z B 2 340 UNP P62873 GBB1_HUMAN 2 340 DBREF 7K7Z G 6 64 UNP P59768 GBG2_HUMAN 6 64 SEQADV 7K7Z ALA A 669 UNP P25098 EXPRESSION TAG SEQRES 1 A 640 LYS LYS ILE LEU LEU PRO GLU PRO SER ILE ARG SER VAL SEQRES 2 A 640 MET GLN LYS TYR LEU GLU ASP ARG GLY GLU VAL THR PHE SEQRES 3 A 640 GLU LYS ILE PHE SER GLN LYS LEU GLY TYR LEU LEU PHE SEQRES 4 A 640 ARG ASP PHE CYS LEU ASN HIS LEU GLU GLU ALA ARG PRO SEQRES 5 A 640 LEU VAL GLU PHE TYR GLU GLU ILE LYS LYS TYR GLU LYS SEQRES 6 A 640 LEU GLU THR GLU GLU GLU ARG VAL ALA ARG SER ARG GLU SEQRES 7 A 640 ILE PHE ASP SER TYR ILE MET LYS GLU LEU LEU ALA CYS SEQRES 8 A 640 SER HIS PRO PHE SER LYS SER ALA THR GLU HIS VAL GLN SEQRES 9 A 640 GLY HIS LEU GLY LYS LYS GLN VAL PRO PRO ASP LEU PHE SEQRES 10 A 640 GLN PRO TYR ILE GLU GLU ILE CYS GLN ASN LEU ARG GLY SEQRES 11 A 640 ASP VAL PHE GLN LYS PHE ILE GLU SER ASP LYS PHE THR SEQRES 12 A 640 ARG PHE CYS GLN TRP LYS ASN VAL GLU LEU ASN ILE HIS SEQRES 13 A 640 LEU THR MET ASN ASP PHE SER VAL HIS ARG ILE ILE GLY SEQRES 14 A 640 ARG GLY GLY PHE GLY GLU VAL TYR GLY CYS ARG LYS ALA SEQRES 15 A 640 ASP THR GLY LYS MET TYR ALA MET LYS CYS LEU ASP LYS SEQRES 16 A 640 LYS ARG ILE LYS MET LYS GLN GLY GLU THR LEU ALA LEU SEQRES 17 A 640 ASN GLU ARG ILE MET LEU SER LEU VAL SER THR GLY ASP SEQRES 18 A 640 CYS PRO PHE ILE VAL CYS MET SER TYR ALA PHE HIS THR SEQRES 19 A 640 PRO ASP LYS LEU SER PHE ILE LEU ASP LEU MET ASN GLY SEQRES 20 A 640 GLY ASP LEU HIS TYR HIS LEU SER GLN HIS GLY VAL PHE SEQRES 21 A 640 SER GLU ALA ASP MET ARG PHE TYR ALA ALA GLU ILE ILE SEQRES 22 A 640 LEU GLY LEU GLU HIS MET HIS ASN ARG PHE VAL VAL TYR SEQRES 23 A 640 ARG ASP LEU LYS PRO ALA ASN ILE LEU LEU ASP GLU HIS SEQRES 24 A 640 GLY HIS VAL ARG ILE SER ASP LEU GLY LEU ALA CYS ASP SEQRES 25 A 640 PHE SER LYS LYS LYS PRO HIS ALA SER VAL GLY THR HIS SEQRES 26 A 640 GLY TYR MET ALA PRO GLU VAL LEU GLN LYS GLY VAL ALA SEQRES 27 A 640 TYR ASP SER SER ALA ASP TRP PHE SER LEU GLY CYS MET SEQRES 28 A 640 LEU PHE LYS LEU LEU ARG GLY HIS SER PRO PHE ARG GLN SEQRES 29 A 640 HIS LYS THR LYS ASP LYS HIS GLU ILE ASP ARG MET THR SEQRES 30 A 640 LEU THR MET ALA VAL GLU LEU PRO ASP SER PHE SER PRO SEQRES 31 A 640 GLU LEU ARG SER LEU LEU GLU GLY LEU LEU GLN ARG ASP SEQRES 32 A 640 VAL ASN ARG ARG LEU GLY CYS LEU GLY ARG GLY ALA GLN SEQRES 33 A 640 GLU VAL LYS GLU SER PRO PHE PHE ARG SER LEU ASP TRP SEQRES 34 A 640 GLN MET VAL PHE LEU GLN LYS TYR PRO PRO PRO LEU ILE SEQRES 35 A 640 PRO PRO ARG GLY GLU VAL ASN ALA ALA ASP ALA PHE ASP SEQRES 36 A 640 ILE GLY SER PHE ASP GLU GLU ASP THR LYS GLY ILE LYS SEQRES 37 A 640 LEU LEU ASP SER ASP GLN GLU LEU TYR ARG ASN PHE PRO SEQRES 38 A 640 LEU THR ILE SER GLU ARG TRP GLN GLN GLU VAL ALA GLU SEQRES 39 A 640 THR VAL PHE ASP THR ILE ASN ALA GLU THR ASP ARG LEU SEQRES 40 A 640 GLU ALA ARG LYS LYS ALA LYS ASN LYS GLN LEU GLY HIS SEQRES 41 A 640 GLU GLU ASP TYR ALA LEU GLY LYS ASP CYS ILE MET HIS SEQRES 42 A 640 GLY TYR MET SER LYS MET GLY ASN PRO PHE LEU THR GLN SEQRES 43 A 640 TRP GLN ARG ARG TYR PHE TYR LEU PHE PRO ASN ARG LEU SEQRES 44 A 640 GLU TRP ARG GLY GLU GLY GLU ALA PRO GLN SER LEU LEU SEQRES 45 A 640 THR MET GLU GLU ILE GLN SER VAL GLU GLU THR GLN ILE SEQRES 46 A 640 LYS GLU ARG LYS CYS LEU LEU LEU LYS ILE ARG GLY GLY SEQRES 47 A 640 LYS GLN PHE ILE LEU GLN CYS ASP SER ASP PRO GLU LEU SEQRES 48 A 640 VAL GLN TRP LYS LYS GLU LEU ARG ASP ALA TYR ARG GLU SEQRES 49 A 640 ALA GLN GLN LEU VAL GLN ARG VAL PRO LYS MET LYS ASN SEQRES 50 A 640 LYS PRO ALA SEQRES 1 B 339 SER GLU LEU ASP GLN LEU ARG GLN GLU ALA GLU GLN LEU SEQRES 2 B 339 LYS ASN GLN ILE ARG ASP ALA ARG LYS ALA CYS ALA ASP SEQRES 3 B 339 ALA THR LEU SER GLN ILE THR ASN ASN ILE ASP PRO VAL SEQRES 4 B 339 GLY ARG ILE GLN MET ARG THR ARG ARG THR LEU ARG GLY SEQRES 5 B 339 HIS LEU ALA LYS ILE TYR ALA MET HIS TRP GLY THR ASP SEQRES 6 B 339 SER ARG LEU LEU VAL SER ALA SER GLN ASP GLY LYS LEU SEQRES 7 B 339 ILE ILE TRP ASP SER TYR THR THR ASN LYS VAL HIS ALA SEQRES 8 B 339 ILE PRO LEU ARG SER SER TRP VAL MET THR CYS ALA TYR SEQRES 9 B 339 ALA PRO SER GLY ASN TYR VAL ALA CYS GLY GLY LEU ASP SEQRES 10 B 339 ASN ILE CYS SER ILE TYR ASN LEU LYS THR ARG GLU GLY SEQRES 11 B 339 ASN VAL ARG VAL SER ARG GLU LEU ALA GLY HIS THR GLY SEQRES 12 B 339 TYR LEU SER CYS CYS ARG PHE LEU ASP ASP ASN GLN ILE SEQRES 13 B 339 VAL THR SER SER GLY ASP THR THR CYS ALA LEU TRP ASP SEQRES 14 B 339 ILE GLU THR GLY GLN GLN THR THR THR PHE THR GLY HIS SEQRES 15 B 339 THR GLY ASP VAL MET SER LEU SER LEU ALA PRO ASP THR SEQRES 16 B 339 ARG LEU PHE VAL SER GLY ALA CYS ASP ALA SER ALA LYS SEQRES 17 B 339 LEU TRP ASP VAL ARG GLU GLY MET CYS ARG GLN THR PHE SEQRES 18 B 339 THR GLY HIS GLU SER ASP ILE ASN ALA ILE CYS PHE PHE SEQRES 19 B 339 PRO ASN GLY ASN ALA PHE ALA THR GLY SER ASP ASP ALA SEQRES 20 B 339 THR CYS ARG LEU PHE ASP LEU ARG ALA ASP GLN GLU LEU SEQRES 21 B 339 MET THR TYR SER HIS ASP ASN ILE ILE CYS GLY ILE THR SEQRES 22 B 339 SER VAL SER PHE SER LYS SER GLY ARG LEU LEU LEU ALA SEQRES 23 B 339 GLY TYR ASP ASP PHE ASN CYS ASN VAL TRP ASP ALA LEU SEQRES 24 B 339 LYS ALA ASP ARG ALA GLY VAL LEU ALA GLY HIS ASP ASN SEQRES 25 B 339 ARG VAL SER CYS LEU GLY VAL THR ASP ASP GLY MET ALA SEQRES 26 B 339 VAL ALA THR GLY SER TRP ASP SER PHE LEU LYS ILE TRP SEQRES 27 B 339 ASN SEQRES 1 G 59 THR ALA SER ILE ALA GLN ALA ARG LYS LEU VAL GLU GLN SEQRES 2 G 59 LEU LYS MET GLU ALA ASN ILE ASP ARG ILE LYS VAL SER SEQRES 3 G 59 LYS ALA ALA ALA ASP LEU MET ALA TYR CYS GLU ALA HIS SEQRES 4 G 59 ALA LYS GLU ASP PRO LEU LEU THR PRO VAL PRO ALA SER SEQRES 5 G 59 GLU ASN PRO PHE ARG GLU LYS HET W4G A 701 37 HETNAM W4G 3-BENZYL-7-(1H-PYRAZOL-4-YL)QUINAZOLIN-4(3H)-ONE FORMUL 4 W4G C18 H14 N4 O HELIX 1 AA1 SER A 38 ARG A 50 1 13 HELIX 2 AA2 THR A 54 SER A 60 1 7 HELIX 3 AA3 GLN A 61 HIS A 75 1 15 HELIX 4 AA4 LEU A 76 GLU A 78 5 3 HELIX 5 AA5 ALA A 79 LEU A 95 1 17 HELIX 6 AA6 THR A 97 ASP A 110 1 14 HELIX 7 AA7 ILE A 113 LEU A 118 1 6 HELIX 8 AA8 SER A 125 LYS A 138 1 14 HELIX 9 AA9 PHE A 146 ASN A 156 1 11 HELIX 10 AB1 GLY A 159 GLU A 167 1 9 HELIX 11 AB2 SER A 168 LEU A 182 1 15 HELIX 12 AB3 THR A 187 ASN A 189 5 3 HELIX 13 AB4 ASP A 223 GLN A 231 1 9 HELIX 14 AB5 GLY A 232 SER A 247 1 16 HELIX 15 AB6 ASP A 278 GLY A 287 1 10 HELIX 16 AB7 SER A 290 ARG A 311 1 22 HELIX 17 AB8 LYS A 319 ALA A 321 5 3 HELIX 18 AB9 SER A 370 ARG A 386 1 17 HELIX 19 AC1 ASP A 398 THR A 408 1 11 HELIX 20 AC2 SER A 418 LEU A 429 1 12 HELIX 21 AC3 ASP A 432 ARG A 436 5 5 HELIX 22 AC4 GLY A 443 LYS A 448 1 6 HELIX 23 AC5 SER A 450 ARG A 454 5 5 HELIX 24 AC6 ASP A 457 LEU A 463 1 7 HELIX 25 AC7 LEU A 499 ARG A 507 5 9 HELIX 26 AC8 ILE A 513 GLU A 523 1 11 HELIX 27 AC9 VAL A 525 GLY A 548 1 24 HELIX 28 AD1 THR A 602 GLU A 604 5 3 HELIX 29 AD2 SER A 636 ARG A 660 1 25 HELIX 30 AD3 GLU B 3 CYS B 25 1 23 HELIX 31 AD4 THR B 29 THR B 34 1 6 HELIX 32 AD5 ILE G 9 ASN G 24 1 16 HELIX 33 AD6 LYS G 29 ALA G 45 1 17 HELIX 34 AD7 LYS G 46 ASP G 48 5 3 HELIX 35 AD8 PRO G 55 ASN G 59 5 5 SHEET 1 AA1 6 PHE A 191 ARG A 199 0 SHEET 2 AA1 6 GLU A 204 LYS A 210 -1 O GLY A 207 N HIS A 194 SHEET 3 AA1 6 MET A 216 CYS A 221 -1 O MET A 219 N TYR A 206 SHEET 4 AA1 6 LEU A 267 LEU A 271 -1 O LEU A 271 N ALA A 218 SHEET 5 AA1 6 MET A 257 HIS A 262 -1 N SER A 258 O ILE A 270 SHEET 6 AA1 6 LEU A 511 THR A 512 -1 O LEU A 511 N ALA A 260 SHEET 1 AA2 2 VAL A 313 VAL A 314 0 SHEET 2 AA2 2 CYS A 340 ASP A 341 -1 O CYS A 340 N VAL A 314 SHEET 1 AA3 2 ILE A 323 LEU A 325 0 SHEET 2 AA3 2 VAL A 331 ILE A 333 -1 O ARG A 332 N LEU A 324 SHEET 1 AA4 6 ARG A 587 ARG A 591 0 SHEET 2 AA4 6 GLN A 577 PHE A 584 -1 N PHE A 584 O ARG A 587 SHEET 3 AA4 6 MET A 561 MET A 568 -1 N MET A 561 O LEU A 583 SHEET 4 AA4 6 GLN A 629 GLN A 633 -1 O GLN A 633 N SER A 566 SHEET 5 AA4 6 ARG A 617 ILE A 624 -1 N LEU A 622 O PHE A 630 SHEET 6 AA4 6 ILE A 606 ILE A 614 -1 N GLU A 610 O LEU A 621 SHEET 1 AA5 4 ARG B 46 LEU B 51 0 SHEET 2 AA5 4 LEU B 336 ASN B 340 -1 O LEU B 336 N LEU B 51 SHEET 3 AA5 4 VAL B 327 SER B 331 -1 N VAL B 327 O TRP B 339 SHEET 4 AA5 4 VAL B 315 VAL B 320 -1 N CYS B 317 O GLY B 330 SHEET 1 AA6 4 ILE B 58 TRP B 63 0 SHEET 2 AA6 4 LEU B 69 SER B 74 -1 O ALA B 73 N TYR B 59 SHEET 3 AA6 4 LYS B 78 ASP B 83 -1 O TRP B 82 N LEU B 70 SHEET 4 AA6 4 LYS B 89 PRO B 94 -1 O ILE B 93 N LEU B 79 SHEET 1 AA7 4 VAL B 100 TYR B 105 0 SHEET 2 AA7 4 TYR B 111 GLY B 116 -1 O GLY B 115 N MET B 101 SHEET 3 AA7 4 ILE B 120 ASN B 125 -1 O TYR B 124 N VAL B 112 SHEET 4 AA7 4 ARG B 134 ALA B 140 -1 O LEU B 139 N CYS B 121 SHEET 1 AA8 4 LEU B 146 PHE B 151 0 SHEET 2 AA8 4 GLN B 156 SER B 161 -1 O SER B 160 N SER B 147 SHEET 3 AA8 4 CYS B 166 ASP B 170 -1 O ALA B 167 N THR B 159 SHEET 4 AA8 4 GLN B 175 PHE B 180 -1 O GLN B 175 N ASP B 170 SHEET 1 AA9 4 VAL B 187 LEU B 192 0 SHEET 2 AA9 4 LEU B 198 ALA B 203 -1 O GLY B 202 N MET B 188 SHEET 3 AA9 4 ALA B 208 ASP B 212 -1 O TRP B 211 N PHE B 199 SHEET 4 AA9 4 CYS B 218 PHE B 222 -1 O GLN B 220 N LEU B 210 SHEET 1 AB1 4 ILE B 229 PHE B 234 0 SHEET 2 AB1 4 ALA B 240 SER B 245 -1 O ALA B 242 N CYS B 233 SHEET 3 AB1 4 CYS B 250 ASP B 254 -1 O PHE B 253 N PHE B 241 SHEET 4 AB1 4 GLN B 259 TYR B 264 -1 O LEU B 261 N LEU B 252 SHEET 1 AB2 4 ILE B 273 PHE B 278 0 SHEET 2 AB2 4 LEU B 284 TYR B 289 -1 O LEU B 286 N SER B 277 SHEET 3 AB2 4 ASN B 293 ASP B 298 -1 O TRP B 297 N LEU B 285 SHEET 4 AB2 4 ARG B 304 ALA B 309 -1 O LEU B 308 N CYS B 294 CISPEP 1 GLU A 551 ASP A 552 0 -2.56 CISPEP 2 ASN A 570 PRO A 571 0 -8.89 SITE 1 AC1 12 ILE A 197 ARG A 199 GLY A 200 GLY A 203 SITE 2 AC1 12 VAL A 205 ALA A 218 VAL A 255 ASP A 272 SITE 3 AC1 12 MET A 274 LEU A 324 SER A 334 ASP A 335 CRYST1 194.679 70.689 111.503 90.00 110.46 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005137 0.000000 0.001916 0.00000 SCALE2 0.000000 0.014146 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009572 0.00000